The issue is simple, Speculative biotechs are getting slaughtered because of profit taking and investors pulling out money due to uncertainty over debt ceiling. SNTS already got slaughtered when the speculative biotechs were DARK GREEN , SNTS used to be DARK RED.
Now the reverse, because remember SNTS has high beta, SNTS already had it's haircut and expectations are that the crises are over.
Probably next week at last minute. It has to be resolved at some point IMO. The high flyers were dumped with ARIA. ACAD, CLDX, no earnings and selling for way too much IMO. OMER and RGDO, so many saying buy them, and now some panic at the thought of being baggies. SNTS will maybe be able to get a good deal on bringing in some new projects or some marketed product. SNTS has cash to invest, some of the weaker ones will probably need to raise.